ConductScience.org, home

Trial · NCT02969044

Results by group184

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 8PF-06651600Baseline45.15Standard Deviation 13.164units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 8PlaceboBaseline44.85Standard Deviation 13.976units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 8PF-06651600Change at Week 8-26.11Standard Deviation 14.834units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 8PlaceboChange at Week 8-17.38Standard Deviation 18.176units on a scale
Number of Participants With Vital Signs AbnormalitiesPF-06651600Sitting DBP >=20 mmHg increase from baseline3Participants
Number of Participants With Vital Signs AbnormalitiesPlaceboSitting DBP >=20 mmHg increase from baseline0Participants
Number of Participants With Vital Signs AbnormalitiesPF-06651600Sitting DBP >=20 mmHg decrease from baseline0Participants
Number of Participants With Vital Signs AbnormalitiesPlaceboSitting DBP >=20 mmHg decrease from baseline1Participants
Number of Participants With Laboratory AbnormalitiesPF-0665160042Participants
Number of Participants With Laboratory AbnormalitiesPlacebo28Participants
Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)PF-06651600AEs20Participants
Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)PlaceboAEs5Participants
Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)PF-06651600SAEs0Participants
Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)PlaceboSAEs0Participants
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PF-06651600Change at Week 1-4.59Standard Deviation 9.409units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PlaceboChange at Week 1-4.52Standard Deviation 7.025units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PF-06651600Change at Week 2-12.82Standard Deviation 10.969units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PlaceboChange at Week 2-8.05Standard Deviation 9.402units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PF-06651600Change at Week 4-17.79Standard Deviation 12.804units on a scale
Change From Baseline in Simple Disease Activity Index (SDAI) Score at Week 1, 2, 4 and 6PlaceboChange at Week 4-12.55Standard Deviation 13.462units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02969044/results